Department of Anesthesiology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clin Proc. 2012 Jul;87(7):674-82. doi: 10.1016/j.mayocp.2012.03.013.
Mayo Clinic has been involved in an ongoing effort to prevent the diversion of controlled substances from the workplace and to rapidly identify and respond when such diversion is detected. These efforts have found that diversion of controlled substances is not uncommon and can result in substantial risk not only to the individual who is diverting the drugs but also to patients, co-workers, and employers. We believe that all health care facilities should have systems in place to deter controlled substance diversion and to promptly identify diversion and intervene when it is occurring. Such systems are multifaceted and require close cooperation between multiple stakeholders including, but not limited to, departments of pharmacy, safety and security, anesthesiology, nursing, legal counsel, and human resources. Ideally, there should be a broad-based appreciation of the dangers that diversion creates not only for patients but also for all employees of health care facilities, because diversion can occur at any point along a long supply chain. All health care workers must be vigilant for signs of possible diversion and must be aware of how to engage a preexisting group with expertise in investigating possible diversions. In addition, clear policies and procedures should be in place for dealing with such investigations and for managing the many possible outcomes of a confirmed diversion. This article provides an overview of the multiple types of risk that result from drug diversion from health care facilities. Further, we describe a system developed at Mayo Clinic for evaluating episodes of potential drug diversion and for taking action once diversion is confirmed.
梅奥诊所一直在参与一项持续的努力，以防止工作场所的受控物质被转移，并在发现这种转移时迅速识别和作出反应。这些努力发现，受控物质的转移并不罕见，不仅会给转移药物的个人带来重大风险，还会给患者、同事和雇主带来风险。我们认为，所有医疗保健机构都应该建立系统，以阻止受控物质的转移，并在转移发生时及时识别和干预。这些系统是多方面的，需要包括药剂科、安全和保障、麻醉、护理、法律顾问和人力资源在内的多个利益相关者之间的密切合作。理想情况下，应该广泛认识到这种转移不仅对患者，而且对医疗保健机构的所有员工都带来的危险，因为转移可能发生在供应链的任何一个环节。所有医疗工作者都必须警惕可能发生的转移迹象，并必须了解如何与具有调查可能转移问题专业知识的现有团体合作。此外，应制定明确的政策和程序来处理此类调查，并管理已确认转移的许多可能结果。本文概述了医疗保健机构药物转移带来的多种类型的风险。此外，我们还描述了梅奥诊所开发的一种系统，用于评估潜在药物转移事件，并在确认转移后采取行动。
